State by State—an Update on Proposed Legislation to Benefit Rheumatology

Referred to Senate Insurance and Banking 25% Missouri SB 1190 Referred to Senate Insurance and Banking 25% New Hampshire SB 354 House Commerce and Consumer Affairs Hearing 5/1 50% Ohio HB 177 Reported: Public Health Policy 25% Oklahoma HB 3368 Passed Insurance Committee 25% Oregon HB 4113 Signed by governor   Pennsylvania SB 372 Senate Banking and Insurance 25% Rhode Island HB 8041 House Corporations Committee held for study 25% Rhode Island S 2720 Referred to House Corporations 50% South Carolina H 3618 House Labor, Commerce, and Industry 25% Tennessee SB 2008 Assigned to General Subcommittee of Commerce and Labor 25% Utah SB 152 Withdrawn   Vermont H 233 Referred to Senate Health and Welfare 50% Wisconsin SB 100, AB 103 Dead           Gold card   Alaska HB 187 House Rules Committee Hearing 4/22 25% Alaska SB 219 Heard in Labor and Commerce (3/13) 25% Colorado HB 1149 Referred to Senate Appropriations 50% Iowa HF 2488 House Fiscal Note 50% Kentucky SB 270 Dead   Missouri HB 1976 Reported and first read in Senate 50% Ohio HB 130 Referred to Insurance Committee 25%     Non-medical switching   Arizona SB 1164 Pending House Rules 50% Mississippi HB 339 Dead   Ohio HB 130 Referred to Insurance Committee 25%     Prescription drug affordability board   Connecticut SB 8 Referred to Senate Judiciary 25% Iowa HF 2408 Commerce Committee 25% Iowa SF 2238 Health and Human Services 25% Kentucky HB 823 Dead   Maryland HB 340 Dead   Maryland SB 388 Dead   Nebraska LB 833 Banking, Commerce, and Insurance Committee 25%